| PMID | Title | Display |
|---|
| 10502292 | Promoter competitors as novel antifibrotics that inhibit transforming growth factor-beta induction of collagen and noncollagen protein synthesis in fibroblasts. |    |
|
| 10535809 | The modulation of corneal keratocyte and epithelial cell responses to poly(2-hydroxyethyl methacrylate) hydrogel surfaces: phosphorylation decreases collagenase production in vitro. | |
|
| 10850855 | Evaluation of chemokine- and phlogistin-mediated leukocyte chemotaxis using an in vivo sponge model. | |
|
| 11336309 | Porosity-graded hydroxyapatite ceramics to replace natural bone. | |
|
| 11455210 | Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. | |
|
| 11494279 | Latency of compound muscle action potentials of the anal sphincter after magnetic sacral stimulation. | |
|
| 12216955 | The complexity of immune and alloimmune response. | |
|
| 12865008 | Diagnosis and surgical treatment of cavernous sinus hemangiomas: an experience of 20 cases. | |
|
| 15325637 | Inducible nonviral gene expression in the treatment of osteochondral defects. | |
|
| 15811317 | Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells. | |
|
